 antithrombotic guidelines.137 All guidelines strongly recommend treatment with a single antiplatelet agent in
persons with symptomatic cardiovascular disease, or
more speciÔ¨Åcally chronic limb threatening ischaemia
(CLTI). These drugs reduce the risk of cardiovascular
events; for the increased risk of gastric bleeding in aspirin
treated individuals, a proton pump inhibitor as additional treatment should be considered. There is less
consensus regarding which drug to choose, clopidog